| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.69M | - | |
| VP | 242.9K | $3.40M | - | |
| Dir | 110.4K | $1.55M | - | |
| CFO | 75.9K | $1.06M | - | |
| Dir | 15.5K | $217.8K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2018 | Stafford John S III | 10% Owner | Sell | 111,700 | $41.42 | $4,626,478.59 | -0.7% | |
| Jul 12, 2018 | Stafford John S III | 10% Owner | Sell | 138,300 | $39.69 | $5,489,265.18 | -0.9% | |
| Jun 20, 2018 | Stafford John S III | 10% Owner | Sell | 250,000 | $39.90 | $9,974,392.49 | -1.5% | |
| Jun 15, 2018 | Dahiyat Bassil I74 | President And CEO | Sale+OE | 50,000 | $40.51 | $2,025,690.00 | -14.6% | |
| Jun 13, 2018 | Kuch John J68 | Sr. Vice President &CFO | Sale+OE | 25,000 | $41.64 | $1,040,945.00 | -30.6% | |
| Mar 15, 2018 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 40,000 | $30.89 | $1,235,744.00 | -100% | |
| Mar 5, 2018 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 20,000 | $29.59 | $591,806.00 | -100% | |
| Feb 27, 2018 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 20,000 | $29.64 | $592,848.00 | -100% | |
| Feb 22, 2018 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 8,069 | $26.00 | $209,794.00 | -100% | |
| Feb 22, 2018 | Foster Paul A | Chief Medical Officer | Sale+OE | 10,000 | $26.03 | $260,300.00 | -80.5% |